|
Fuzeon -- A Review of the First Entry Inhibitor
Entry Inhibitors: A New Class of HIV Medications
2003 How Does HIV Enter Our Cells?To damage the immune system, HIV must first get inside your CD4 cells, which are responsible for fighting off diseases inside your body. After HIV enters your CD4 cells, it uses several enzymes to turn the cells into factories that produce more HIV. Two of the key enzymes that HIV uses once it gets inside a CD4 cell are the reverse transcriptase and protease enzymes, which have been the focus of the first three available classes of HIV medications. Researchers have figured out several of the critical steps that HIV follows to get inside CD4 cells. This has been broken down into a few stages. Here's a play-by-play look at what happens:
The goal of Fuzeon, the first entry inhibitor to be approved in the U.S., is to prevent HIV from entering CD4 cells by stopping it from "zipping" together the two ends of the glycoprotein. This article is a part of the publication Fuzeon -- A Review of the First Entry Inhibitor, copyright 2003, Body Health Resources Corporation. |